Registry of Lobbyists
Version 1 of 3 (2003-02-14 to 2004-02-26) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
MERCK FROSST CANADA INC
16711 TRANSCANADA HIGHWAY KIRKLAND, QC H9H 3L1 Canada |
| Telephone number: | 514-428-8571 |
| Fax number: | 514-428-4957 |
| Responsible officer name and position during the period of this registration: | ALAIN BOISVERT, DIRECTOR, CORPORATE AFFAIRS (EASTERN REGION) |
| Description of activities: | MERCK FROSST IS CANADA'S LARGEST INTEGRATED PHARMACEUTICAL COMPANY, WITH OVER 1300 INDIVIDUALS ENGAGED IN DISCOVERING, MANUFACTURING AND MARKETING MEDICINES AND VACCINES FOR HUMAN HEALTH AND ANIMAL HEALTH PRODUCTS.THE MANUFACTURING DIVISION OF MERCK FROSST CANADA PRODUCES OVER 150 PRESCRIPTIONS AND OVER-THE-COUNTER MEDICINES FOR NATIONAL AND INTERNATIONAL MARKETS. |
| Parent: | The corporation is not a subsidiary of any other parent corporations. |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Federal Office of Regional Development – Quebec (FORD[Q]), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Justice Canada (JC), Office of the Information and Privacy Commissioner (OIPC), Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Treasury Board Of Canada Secretariat (TBS) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Constitutional Issues, Health, Industry, Intellectual Property, Internal Trade, International Relations, International Trade, Justice and Law Enforcement, Regional Development, Science and Technology, Taxation and Finance |
| Subject Matter: Particulars: | ANY FURTHER PROPOSALS FOR CHANGE TO DRUG PATENT LEGISLATION (FORMERLY BILL C-91); PMPRB PRICING GUIDELINES POLICY; PHARMACARE / HEALTH POLICIES |